AbCellera Biologics Inc vs Nutrien Ltd — how do they compare? AbCellera Biologics Inc trades at $9.2 (market cap $2.99B), while Nutrien Ltd trades at $67.3 (market cap $32.05B). The key difference: Nutrien Ltd is far larger — about 10.7× AbCellera Biologics Inc's market cap, and Nutrien Ltd pays a 3.27% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | NTR | |
|---|---|---|
Market Cap | $2.99B | $32.05B |
Sector | Health | Basic Materials |
52-Week High | $9.76 | $83.94 |
52-Week Low | $2.78 | $53.64 |
Enterprise Value | $2.58B | $43.86B |
Dividend Yield | — | 3.27% |
Trailing returns across standard periods
Latest headlines on both assets
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients--nitrogen, potash, and phosphate--although its main focus is potash, where it is the global leader in installed capacity with roughly 20% share. The company is also the largest agricultural retailer in the United States, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.
Read more on NTR →